Monthly Archives: September 2015

Real World Evidence Making Headlines

Click here to subscribe to SVMPharma’s RWE updates

Latest Updates

Unique real-world study in diabetic macular oedema (DMO)
First real-world multicentre study of the use of inhaled aztreonam lysine for cystic fibrosis (CF)
DESERVE showed significant benefits in NHS healthcare savings
A retrospective cohort study of the clinical outcomes of ILUVIEN in four ophthalmology centres in Portugal (ICEPT)
SVMPharma’s real-world studies in diabetic eye oedema led to multiple successful publications and congress presentations in the UK and Europe

Quick Links

Real World Evidence Old
Global Real World Evidence
Additional Services
Technology
Privacy Policy
Contact Us

About SVMPharma

SVMPharma is a bespoke strategic consultancy based in Hampshire UK, specialising in Real World Evidence (RWE) for the pharmaceutical and healthcare industries. At SVMPharma we also cover Global RWE, Patient Experience, Big Data Analytics and Influence Mapping alongside Additional Services. Find further information and read our latest articles in the Resource Centre.

+44 (0)1252 417030

Quick Links

Real World Evidence Old
Global Real World Evidence
Additional Services
Technology
Privacy Policy
Contact Us

Twitter

Tweets by @SVMPharma

Latest News

Winners announced for the Medical & Scientific Excellence Awards! December 7, 2018
Mereo BioPharma and OncoMed propose merger December 7, 2018
AZ’ Imfinzi fails in head and neck cancer trial December 7, 2018
Mallinckrodt to split business December 7, 2018
NICE OKs NHS funding for Gilead’s CAR T-cell therapy December 7, 2018

Privacy Policy
Website Disclaimer
Sitemap